News

Video

Testing for IDH1 Mutations in Biliary Tract Cancers

Related Videos
Bartosz Chmielowski, MD
Raza Hoda, MD, FASCP
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Timothy S. Fenske, MD, MS
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
2 experts in this video
2 experts in this video
Preliminary Results from the IMMagine-1 Trial
Related Content
Image credit: © TensorSpark – stock.adobe.com
January 10th 2025

Emiltatug Ledadotin Generates Positive Initial Data in Advanced/Metastatic Solid Tumors

Oncology PER® Spectives™: Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma
January 9th 2025

Oncology PER® Spectives™: Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma

Christopher Graham, MD, of University of Minnesota Medical School
January 10th 2025

Axatilimab Shakes Up cGVHD Treatment and Looks to Move to Earlier Line in Paradigm

Clinical Practice Insights Reveal the Complexity of Lymphoma Subtypes and Advances in First-Line Treatments: With Chandler Park, MD; and Joshua Brody, MD
January 8th 2025

Clinical Practice Insights Reveal the Complexity of Lymphoma Subtypes and Advances in First-Line Treatments: With Chandler Park, MD; and Joshua Brody, MD

Maris– stock.adobe.com
January 10th 2025

ctDNA Testing Joins NCCN Guidelines for MRD Assessment in DLBCL

Cancer | Image Credit: © Cornflakesei - stock.adobe.com
January 10th 2025

Sasanlimab Plus BCG Meets EFS End Point in BCG-Naive, High-Risk NMIBC